デフォルト表紙
市場調査レポート
商品コード
1439469

胎児モニタリング装置の世界市場:洞察、競合情勢、市場予測:2030年

Fetal Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
胎児モニタリング装置の世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の胎児モニタリング装置の市場規模は、2023年に31億6,000万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に6.92%のCAGRで拡大し、2030年には47億2,000万米ドルに達すると予測されています。胎児モニタリング装置の需要増加は、主に、様々な先天性欠損症や早産の有病率、妊娠後期の胎児をモニタリングする必要性の増加、技術的に高度な胎児モニターの開発、低侵襲処置の採用拡大、世界中の母体と胎児の健康のための政府および非政府イニシアチブの増加が市場を強化していることに起因し、それによって2024年から2030年までの予測期間中に胎児モニタリング装置市場の成長に貢献すると予測されています。

胎児モニタリング装置市場は、様々な理由によって製品需要が伸びています。製品需要の主な理由は、さまざまな先天性異常のために胎児を監視する必要性の増加によるものです。

米国疾病管理予防センター(CDC)2022によると、先天性心疾患(CHD)は先天性欠損症の中で最も一般的なタイプです。一部のCHD、特に軽度のCHDの有病率(全出生数に対する心臓欠陥を持って生まれた赤ちゃんの数)は増加しています。

さらに、上記の出典にあるように、低出生体重児、早産、多胎、妊娠中の感染症は、多くの発達障害のリスク増加と関連しています。

また、早産の有病率も、これらの胎児モニタリング装置の使用を引き起こすもう1つの要因です。WHO2018によると、184カ国で早産の割合は出生児の5%から18%です。毎年、推定1,500万人の赤ちゃんが早産(妊娠37週未満)で生まれており、この数は増加傾向にあります。

さらに、COVID-19感染によって胎児を監視する必要性が高まっています。

当レポートでは、世界の胎児モニタリング装置市場について調査し、市場の概要とともに、製品別、方法別、ポータビリティ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 胎児モニタリング装置市場レポートのイントロダクション

第2章 胎児モニタリング装置市場のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 胎児モニタリング装置市場の主な要因分析

  • 胎児モニタリング装置市場の促進要因
  • 胎児モニタリング装置市場の抑制要因と課題
  • 胎児モニタリング装置市場の機会

第5章 胎児モニタリング装置市場におけるポーターのファイブフォース分析

第6章 胎児モニタリング装置市場に対するCOVID-19の影響分析

第7章 胎児モニタリング装置市場の概要

  • 製品別
  • 方法別
  • ポータビリティ別
  • エンドユーザー別
  • 地域別

第8章 胎児モニタリング装置市場の世界企業シェア分析-主要3~5社

第9章 胎児モニタリング装置市場の企業と製品のプロファイル

  • Koninklijke Philips N.V.
  • General Electric Company
  • Cardinal Health
  • Nidek Medical
  • Siemens Healthcare GmbH
  • Heal Force
  • Medgyn Products, Inc.
  • Promed Technology Co., Limited
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • Narang Medical Limited
  • Trivitron Healthcare
  • Neoventa Medical AB
  • Huntleigh Healthcare Ltd
  • EDAN Instruments, Inc.
  • Shenzhen Bestman Instrument Co., Ltd.
  • Natus Medical Incorporated
  • CooperSurgical Inc.
  • Contec Medical Systems Co., Ltd
  • Life Plus Healthcare (P) Ltd.
  • Bionet

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Fetal Monitoring Devices Market in Global (2021-2030)
  • Table 4: Fetal Monitoring Devices Market in Global by Product (2021-2030)
  • Table 5: Fetal Monitoring Devices Market in Global by Method (2021-2030)
  • Table 6: Fetal Monitoring Devices Market in Global by Portability (2021-2030)
  • Table 7: Fetal Monitoring Devices Market in Global by End User (2021-2030)
  • Table 8: Fetal Monitoring Devices Market in Global by Geography (2021-2030)
  • Table 9: Fetal Monitoring Devices Market in North America (2021-2030)
  • Table 10: Fetal Monitoring Devices Market in North America by Country (2021-2030)
  • Table 11: Fetal Monitoring Devices Market in the US (2021-2030)
  • Table 12: Fetal Monitoring Devices Market in Canada (2021-2030)
  • Table 13: Fetal Monitoring Devices Market in Mexico (2021-2030)
  • Table 14: Fetal Monitoring Devices Market in Europe (2021-2030)
  • Table 15: Fetal Monitoring Devices Market in Europe by Country (2021-2030)
  • Table 16: Fetal Monitoring Devices Market in France (2021-2030)
  • Table 17: Fetal Monitoring Devices Market in Germany (2021-2030)
  • Table 18: Fetal Monitoring Devices Market in the United Kingdom (2021-2030)
  • Table 19: Fetal Monitoring Devices Market in Italy (2021-2030)
  • Table 20: Fetal Monitoring Devices Market in Spain (2021-2030)
  • Table 21: Fetal Monitoring Devices Market in Russia (2021-2030)
  • Table 22: Fetal Monitoring Devices Market in Rest of Europe (2021-2030)
  • Table 23: Fetal Monitoring Devices Market in APAC (2021-2030)
  • Table 24: Fetal Monitoring Devices Market in APAC by Country (2021-2030)
  • Table 25: Fetal Monitoring Devices Market in China (2021-2030)
  • Table 26: Fetal Monitoring Devices Market in Japan (2021-2030)
  • Table 27: Fetal Monitoring Devices Market in India (2021-2030)
  • Table 28: Fetal Monitoring Devices Market in Australia (2021-2030)
  • Table 29: Fetal Monitoring Devices Market in South Korea (2021-2030)
  • Table 30: Fetal Monitoring Devices Market in Rest of APAC (2021-2030)
  • Table 31: Fetal Monitoring Devices Market in Rest of World (2021-2030)
  • Table 32: Fetal Monitoring Devices Market in RoW by Region (2021-2030)
  • Table 33: Fetal Monitoring Devices Market in Middle East (2021-2030)
  • Table 34: Fetal Monitoring Devices Market in Africa (2021-2030)
  • Table 35: Fetal Monitoring Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Fetal Monitoring Devices Market in Global (2021-2030)
  • Figure 4: Fetal Monitoring Devices Market in Global by Product (2021-2030)
  • Figure 5: Fetal Monitoring Devices Market in Global by Method (2021-2030)
  • Figure 6: Fetal Monitoring Devices Market in Global by Portability (2021-2030)
  • Figure 7: Fetal Monitoring Devices Market in Global by End User (2021-2030)
  • Figure 8: Fetal Monitoring Devices Market in Global by Geography (2021-2030)
  • Figure 9: Fetal Monitoring Devices Market in North America (2021-2030)
  • Figure 10: Fetal Monitoring Devices Market in North America by Country (2021-2030)
  • Figure 11: Fetal Monitoring Devices Market in the US (2021-2030)
  • Figure 12: Fetal Monitoring Devices Market in Canada (2021-2030)
  • Figure 13: Fetal Monitoring Devices Market in Mexico (2021-2030)
  • Figure 14: Fetal Monitoring Devices Market in Europe (2021-2030)
  • Figure 15: Fetal Monitoring Devices Market in Europe by Country (2021-2030)
  • Figure 16: Fetal Monitoring Devices Market in France (2021-2030)
  • Figure 17: Fetal Monitoring Devices Market in Germany (2021-2030)
  • Figure 18: Fetal Monitoring Devices Market in the United Kingdom (2021-2030)
  • Figure 19: Fetal Monitoring Devices Market in Italy (2021-2030)
  • Figure 20: Fetal Monitoring Devices Market in Spain (2021-2030)
  • Figure 21: Fetal Monitoring Devices Market in Russia (2021-2030)
  • Figure 22: Fetal Monitoring Devices Market in Rest of Europe (2021-2030)
  • Figure 23: Fetal Monitoring Devices Market in APAC (2021-2030)
  • Figure 24: Fetal Monitoring Devices Market in APAC by Country (2021-2030)
  • Figure 25: Fetal Monitoring Devices Market in China (2021-2030)
  • Figure 26: Fetal Monitoring Devices Market in Japan (2021-2030)
  • Figure 27: Fetal Monitoring Devices Market in India (2021-2030)
  • Figure 28: Fetal Monitoring Devices Market in Australia (2021-2030)
  • Figure 29: Fetal Monitoring Devices Market in South Korea (2021-2030)
  • Figure 30: Fetal Monitoring Devices Market in Rest of APAC (2021-2030)
  • Figure 31: Fetal Monitoring Devices Market in Rest of World (2021-2030)
  • Figure 32: Fetal Monitoring Devices Market in RoW by Region (2021-2030)
  • Figure 33: Fetal Monitoring Devices Market in Middle East (2021-2030)
  • Figure 34: Fetal Monitoring Devices Market in Africa (2021-2030)
  • Figure 35: Fetal Monitoring Devices Market in South America (2021-2030)
  • Figure 36: Market Drivers
  • Figure 37: Market Barriers
  • Figure 38: Marker Opportunities
  • Figure 39: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0282

Fetal Monitoring Devices Market By Product (Ultrasound Devices [2D Ultrasound, 3D & 4D Ultrasound], Electronic Maternal/Fetal Monitors, Fetal Doppler Devices, Telemetry Devices, Others), By Method (Invasive, Non-Invasive), By Portability (Portable, Non-Portable), By End-User (Hospitals, Obstetrics & Gynecology Clinics, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to increased need for monitoring fetus and increase in government and non-government initiatives for maternal and fetal health

Global Fetal Monitoring Devices Market was valued at USD 3.16 Billion in 2023, growing at a CAGR of 6.92% during the forecast period from 2024 to 2030 to reach USD 4.72 Billion by 2030. The increase in demand for Fetal Monitoring Devices is primarily attributed to the increased need for monitoring fetus for various birth defects and prevalence of preterm births, post-term pregnancy, development of technologically advanced fetal monitors, growing adoption of minimally invasive procedures, and increase in government and non-government initiatives for maternal and fetal health across the world are anticipated to bolster the market, thereby contributing to the growth of the Fetal Monitoring Devices market during the forecast period from 2024-2030.

Fetal Monitoring Devices Market Dynamics:

The Fetal Monitoring Devices market is witnessing a growth in product demand owing to various reasons. The major reason responsible for product demand is due to an increased need for monitoring fetuses for various birth defects.

According to the Centers for Disease Control and Prevention (CDC) 2022, congenital heart defects (CHDs) are the most common types of birth defects. The prevalence (the number of babies born with heart defects compared to the total number of births) of some CHDs, especially mild types, is increasing.

Moreover, as per the above source, low birth weight, premature birth, multiple births, and infections during pregnancy are associated with an increased risk for many developmental disabilities.

Also, the prevalence of preterm births is another factor responsible for the use of these fetal monitoring devices. As per WHO 2018, across 184 countries, the rate of preterm birth ranges from 5% to 18% of babies born. Every year, an estimated 15 million babies are born preterm (before 37 completed weeks of gestation), and this number is rising.

Furthermore, there was more need for monitoring the fetus due to the COVID-19 infection.

According to the CDC's Surveillance for Emerging Threats to Mothers and Babies Network 2022 findings, among 25,896 infants born to women with SARS-CoV-2 infection during pregnancy, 3,381 (13%) were tested for COVID-19. Scientists found that 4% of tested infants had a positive test result and were born to both symptomatic and asymptomatic women. Nearly all positive newborns were born to women with infections closer to delivery.

Therefore, with proper monitoring, these defects can be prevented by undergoing proper care and medication. Hence, the growth of the Fetal Monitoring Devices Market is expected to rise during the forecast period from 2024 to 2030.

However, the risk involved with invasive fetal monitoring and the high cost of equipment may be certain limiting factors of the Fetal Monitoring Devices market growth.

The market witnessed a COVID-19 outbreak which extensively instigated increased use of Fetal Monitoring Devices. People who have COVID-19 during pregnancy were at increased risk for complications that can affect their pregnancy and developing baby. For example, COVID-19 during pregnancy increases the risk of delivering preterm (earlier than 37 weeks) and or stillborn infant. This resulted in the increased demand for Fetal Monitoring Devices during the pandemic. Moreover, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post pandemically made the resumption of regular healthcare services, which will keep the demand for these products on course in the Fetal Monitoring Devices market.

Fetal Monitoring Devices Market Segment Analysis:

Fetal Monitoring Devices Market By Product (Ultrasound Devices [2D Ultrasound, 3D & 4D Ultrasound], Electronic Maternal/Fetal Monitors, Fetal Doppler Devices, Telemetry Devices, Others), By Method (Invasive, Non-Invasive), By Portability (Portable, Non-Portable), By End-User (Hospitals, Obstetrics & Gynecology Clinics, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product segment of the Fetal Monitoring Devices market, the Electronic Maternal/Fetal Monitors are estimated to hold a higher share in the Fetal Monitoring Devices market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with the monitoring of the fetus.

These devices help to hear the baby's heartbeat. Also, studies have shown that continuous monitoring reduces the chance that the fetus will have a seizure after birth.

Furthermore, advantageous properties such as detecting changes in the normal heart rate pattern during labor, or preventing unnecessary treatments. As well, doctors advise monitoring throughout labor (continuous) in a high-risk pregnancy, where these devices are effectively used.

Moreover, the product launches in the local markets, in turn, drive the product demand in the market. For instance, in June 2022, remote pregnancy monitoring company Nuvo Group announced the FDA supplemental 510(k) clearance to add a new uterine activity module to its INVU system. INVU is a physician-prescribed, wearable pregnancy monitor that allows women to remotely collect fetal and maternal heart rates - and now uterine activity - while sharing data in real-time with their doctor.

Therefore, the advantages offered by the Electronic Maternal/Fetal Monitors in Fetal Monitoring Devices are predicted to contribute to the increasing demand, thereby driving the growth of the overall Fetal Monitoring Devices market during the forecast period.

North America is expected to dominate the overall Fetal Monitoring Devices Market:

Among all the regions, North America is expected to account for the largest share in the global Fetal Monitoring Devices market. Factors such as the growing prevalence of various birth defects in the fetus, higher cases of preterm births and increases government initiatives are expected to aid in the growth of the North America Fetal Monitoring Devices Market.

According to the CDC 2022, congenital heart defects affect nearly 1% of-or about 40,000-births per year in the United States.

Furthermore, as per the Centers for Disease Control and Prevention 2019, preterm birth affected 1 of every 10 infants born in the United States.

Additionally, according to the same statistics, in 2019, the rate of preterm birth among African-American women (14.4%) was about 50% higher than the rate of preterm birth among white or Hispanic women (9.3% and 10% respectively). Moreover, in 2018, preterm birth accounted for about 17% of infant deaths (deaths before 1 year of age). Thus, the burgeoning cases of premature births will contribute to the growth of the Fetal Monitoring Devices market.

Furthermore, the government of the country is actively involved in maternal and fetal health initiatives across the country. As per the CDC 2022, currently, there are a number of state-based birth defects programs that track CHDs among newborns and young children.

Therefore, the rising prevalence of these defects in the country would result in the rising demand for treatments that make use of Fetal Monitoring Devices, which in turn would provide a conducive growth environment for the United States Fetal Monitoring Devices market as well as the North American region.

Hence, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Fetal Monitoring Devices market during the forecast period.

Fetal Monitoring Devices Market Key Players:

Some of the key market players operating in the Fetal Monitoring Devices market include Koninklijke Philips N.V., General Electric Company, Cardinal Health, Nidek Medical, Siemens Healthcare GmbH, Heal Force, Medgyn Products, Inc., Promed Technology Co., Limited, Shenzhen Comen Medical Instruments Co., Ltd., Narang Medical Limited, Trivitron Healthcare, Neoventa Medical AB, Huntleigh Healthcare Ltd, EDAN Instruments, Inc., Shenzhen Bestman Instrument Co., Ltd., Natus Medical Incorporated, CooperSurgical Inc., Contec Medical Systems Co., Ltd, Life Plus Healthcare (P) Ltd., Bionet, among others.

Recent Developmental Activities in the Fetal Monitoring Devices Market:

In February 2022, CooperSurgical set to acquire Cook Medical's Reproductive Health Division to expand its offerings of ob-gyn and fertility medical devices.

In June 2022, Remote pregnancy monitoring company Nuvo Group announced the FDA supplemental 510(k) clearance to add a new uterine activity module to its INVU system. INVU is a physician-prescribed, wearable pregnancy monitoring system.

In June 2020, Royal Philips announced its launch of an addition to its remote patient monitoring platform for at-risk populations during the COVID-19 pandemic. Philips added the Avalon CL fetal and maternal pod and patch for reducing unnecessary physical interactions between clinicians and patients to prevent transmission of the coronavirus.

Key Takeaways from the Fetal Monitoring Devices Market Report Study

  • Market size analysis for current Fetal Monitoring Devices market size (2023), and market forecast for 5 years (2022-2026)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Fetal Monitoring Devices market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global Fetal Monitoring Devices market.
  • Various opportunities available for the other competitor in the Fetal Monitoring Devices market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current Fetal Monitoring Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Fetal Monitoring Devices market growth in the coming future?

Target Audience who can be benefited from this Fetal Monitoring Devices Market Report Study

  • Fetal Monitoring Devices products providers
  • Research organizations and consulting companies
  • Fetal Monitoring Devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Fetal Monitoring Devices
  • Various End-users who want to know more about the Fetal Monitoring Devices market and latest technological developments in the Fetal Monitoring Devices market.

Frequently Asked Questions for Fetal Monitoring Devices Market:

1. What are Fetal Monitoring Devices?

Fetal monitoring devices are medical devices that consist of a monitoring unit, cables, and electrodes. They are designed to measure, record, and display fetal heart rate, uterine contractions, and/or maternal blood pressure, and heart rate before and during childbirth.

2. What is the market for Global Fetal Monitoring Devices?

Global Fetal Monitoring Devices Market was valued at USD 3.16 Billion in 2023, growing at a CAGR of 6.92% during the forecast period from 2024 to 2030 to reach USD 4.72 Billion by 2030.

3. What are the drivers for the Global Fetal Monitoring Devices Market?

The Fetal Monitoring Devices market is witnessing a positive market growth owing to the increased need for monitoring fetuses for various birth defects and prevalence of preterm births, post-term pregnancy, development of technologically advanced fetal monitors, growing adoption of minimally invasive procedures, and increase in government and non-government initiatives for maternal and fetal health across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Fetal Monitoring Devices Market?

Some of the key market players operating in the Fetal Monitoring Devices market include Koninklijke Philips N.V., General Electric Company, Cardinal Health, Nidek Medical, Siemens Healthcare GmbH, Heal Force, Medgyn Products, Inc., Promed Technology Co., Limited, Shenzhen Comen Medical Instruments Co., Ltd., Narang Medical Limited, Trivitron Healthcare, Neoventa Medical AB, Huntleigh Healthcare Ltd, EDAN Instruments, Inc., Shenzhen Bestman Instrument Co., Ltd., Natus Medical Incorporated, CooperSurgical Inc., Contec Medical Systems Co., Ltd, Life Plus Healthcare (P) Ltd., Bionet and others.

5. Which region has the highest share in Fetal Monitoring Devices Market?

North America is expected to hold the highest share in the revenue in the Fetal Monitoring Devices market during the forecast period. Factors such as the growing prevalence of various birth defects in the fetus, higher cases of preterm births and increases government initiatives are expected to aid in the growth of the North America Fetal Monitoring Devices Market in this region.

Table of Contents

1.Fetal Monitoring Devices Market Report Introduction

2.Fetal Monitoring Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Fetal Monitoring Devices Market Key Factors Analysis

  • 4.1. Fetal Monitoring Devices Market Drivers
    • 4.1.1. Increased Need For Monitoring Fetus For Various Birth Defects and Prevalence of Preterm Births, Post Term Pregnancy
    • 4.1.2. Growing Adoption of Minimally Invasive Procedures
    • 4.1.3. Development of Technologically Advanced Fetal Monitors
    • 4.1.4. Increase In Government and Non-government Initiatives For Maternal and Fetal Health Across The World
  • 4.2. Fetal Monitoring Devices Market Restraints and Challenges
    • 4.2.1. The Risk involved with Invasive Fetal Monitoring
    • 4.2.2. The High Cost of Equipment
  • 4.3. Fetal Monitoring Devices Market Opportunities
    • 4.3.1. Development of Advanced Devices that Eliminates the Risky Effects on the Fetus
    • 4.3.2. Rising Need for at-home Monitoring Devices

5. Fetal Monitoring Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Fetal Monitoring Devices Market

7. Fetal Monitoring Devices Market Layout

  • 7.1. By Product
    • 7.1.1. Ultrasound Devices
      • 7.1.1.1. 2D Ultrasound
      • 7.1.1.2. 3D & 4D Ultrasound
    • 7.1.2. Electronic Maternal/Fetal Monitors
    • 7.1.3. Fetal Doppler Devices
    • 7.1.4. Telemetry Devices
    • 7.1.5. Others
  • 7.2. By Method
    • 7.2.1. Invasive
    • 7.2.2. Non-Invasive
  • 7.3. By Portability
    • 7.3.1. Portable
    • 7.3.2. Non-Portable
  • 7.4. By End User
    • 7.4.1. Hospitals
    • 7.4.2. Obstetrics & Gynecology Clinics
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. North America Fetal Monitoring Devices Market, by Country
      • 7.5.1.1.1. United States
      • 7.5.1.1.2. Canada
      • 7.5.1.1.3. Mexico
    • 7.5.2. Europe
      • 7.5.2.1. Europe Fetal Monitoring Devices Market, by Country
      • 7.5.2.1.1. France
      • 7.5.2.1.2. Germany
      • 7.5.2.1.3. United Kingdom
      • 7.5.2.1.4. Italy
      • 7.5.2.1.5. Spain
      • 7.5.2.1.6. Russia
      • 7.5.2.1.7. Rest of Europe
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. Asia-Pacific Fetal Monitoring Devices Market, by Country
      • 7.5.3.1.1. China
      • 7.5.3.1.2. Japan
      • 7.5.3.1.3. India
      • 7.5.3.1.4. Australia
      • 7.5.3.1.5. South Korea
      • 7.5.3.1.6. Rest of Asia Pacific
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. RoW Fetal Monitoring Devices Market, by Region
      • 7.5.4.1.1. Middle East
      • 7.5.4.1.2. Africa
      • 7.5.4.1.3. South America

8. Fetal Monitoring Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Fetal Monitoring Devices Market Company and Product Profiles

  • 9.1. Koninklijke Philips N.V.
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. General Electric Company
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Cardinal Health
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Nidek Medical
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Siemens Healthcare GmbH
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Heal Force
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Medgyn Products, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Promed Technology Co., Limited
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Shenzhen Comen Medical Instruments Co., Ltd.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Narang Medical Limited
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Trivitron Healthcare
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Neoventa Medical AB
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Huntleigh Healthcare Ltd
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. EDAN Instruments, Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Shenzhen Bestman Instrument Co., Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Natus Medical Incorporated
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. CooperSurgical Inc.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Contec Medical Systems Co., Ltd
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Life Plus Healthcare (P) Ltd.
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Bionet
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us